Schedule 13G ownership disclosure
EAGLE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 269796108
Event date: 2024-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,962,070
- Percent of class
- 15.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-077704
- Form type
- SC 13G
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Jul 03, 2024
- Reporting period
- Jun 30, 2024
- Description
- Schedule 13G beneficial ownership